Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled, Multicenter Phase III Study for the Efficacy and Tolerability of Triple Therapy With Esomeprazole, Moxifloxacin and Amoxicillin for Rescue Therapy of Helicobacter Pylori Infection

NCT00455806 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT00455806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00455806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled, Multicenter Phase III Study for the Efficacy and Tolerability of Triple Therapy With Esomeprazole, Moxifloxacin and Amoxicillin for Rescue Therapy of Helicobacter Pylori Infection
Lead sponsor
Technische Universität Dresden
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2007
Completion date
February 29, 2008
Enrollment
132
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic gastritis, helicobacter pylori infection